COVID-19 Vaccination Providers

Resources, guidance, and other information for those providers enrolled or interested in enrolling in Idaho's COVID-19 Vaccination Program. Updates will be made frequently as new information is released.

New COVID-19 Vaccine Capacity, Safety, and Reporting Grants can be used by enrolled vaccine provider organizations to increase staffing to administer shots, purchase needed equipment and supplies, and improve vaccine access for hard-to-reach and vulnerable populations.

For information on priority groups and Idaho COVID-19 data and please visit

COVID-19 Provider Enrollment

Enrollment Information

The Idaho Immunization Program (IIP) is responsible for enrolling organizations that will receive COVID-19 vaccine ordered through the State of Idaho. Strong vaccination partners are key to successfully administer COVID-19 vaccine among priority populations throughout the vaccination campaign. To receive and administer COVID-19 vaccine, your organization must complete the Centers for Disease Control and Prevention’s (CDC) COVID-19 Vaccination Program Provider Agreement and submit the agreement to the IIP.

Please review the following general information prior to completing the CDC COVID-19 Vaccination Program Provider Agreement:

  • COVID-19 vaccine will be distributed by the federal government at no cost to enrolled COVID-19 vaccination providers.
  • COVID-19 vaccination providers must administer COVID-19 vaccine regardless of the vaccine recipient’s ability to pay administration fees or their health plan coverage status.
    • According to recent guidance from the Centers for Medicare and Medicaid Services (CMS), COVID-19 vaccination providers may seek reimbursement from a program or plan that covers COVID-19 vaccine administration fees for the vaccine recipient.
    • COVID-19 vaccination providers may not seek any reimbursement, including through balance billing, from the vaccine recipient.
  • COVID-19 vaccination providers must document vaccine administration in the patient’s electronic health record  or PrepMod  within 24 hours of administration, and report administration data to Idaho’s Immunization Reminder Information System (IRIS) as soon as practicable, but no later than 72 hours after administration.
  • All COVID-19 vaccination providers must report physical COVID-19 vaccine inventory daily into VaccineFinder.
  • IIP will provide training and resources for the following topics:
    • Advisory Committee on Immunization Practices (ACIP) and National Academy of Medicine (NAM) Recommendations
    • Vaccine Storage & Handling (i.e., temperature monitoring, vaccine transport, temperature incidents)
    • Vaccine Ordering
    • Inventory Management
    • Vaccine Administration
    • Reporting Systems (i.e., IRIS, PrepMod, electronic data exchange, VaccineFinder)
    • Second Dose Reminders
    • Emergency Use Agreement and/or Vaccine Information Statement Use
    • Vaccine Safety Monitoring and Reporting
  • Submitting a completed agreement is not a binding commitment to administer COVID-19 vaccine. Organizations may withdraw at any time. 
  • Ancillary supply kits are distributed by the federal government at no cost to enrolled COVID-19 vaccination providers. Each kit contains supplies to administer 100 doses of vaccine, including 105 needles (various sizes for the population served by the ordering vaccination provider), 105 syringes, 210 alcohol prep pads, four surgical masks, and two face shields (per kit) for vaccinators, and 100 COVID-19 vaccination record cards for each vaccine recipient.
Prior to Enrollment

Verify your organization can meeting the following criteria prior to submitting the CDC COVID-19 Vaccination Program Provider Agreement:

Completing the Agreement

There are two sections to the CDC COVID-19 Vaccination Program Provider Agreement.

  • Section A lists the requirements and is the legal agreement for program participation.
  • Section B is the information needed for each location receiving or storing vaccine and covered by the organization listed in (Section A.

The agreement requires extensive information about your organization and associated locations (facilities) and requires a signature from both your Chief Medical Officer (CMO) and Chief Executive Officer (or Chief Fiduciary) or equivalent.  

Idaho is using COVIDReadi to collect the enrollment information (

For your convenience, multiple parties (i.e., leadership at your organization) may contribute to completing the agreement. After completing Section A, you will be issued a unique passcode that you can share with associated locations (facilities) that desire to receive and administer COVID-19 vaccine.

Section B (a provider profile) must be submitted for every location storing COVID-19 vaccine for 24 hours or more.

  • Section B does not need to be completed for temporary/off-site settings; however, the organization providing COVID-19 vaccine must indicate that a temporary/off-site setting will be used for vaccine administration.
  • Additional locations (Section B) may be submitted at any time throughout the campaign.
  • The number of locations (Section B) should be indicated in the agreement (Section A).

Have the following information available to complete Section B:

  • If enrolled in the Vaccines for Children (VFC) program, then the VFC pin number is needed. An organization is not required to be enrolled in the VFC program to enroll in the COVID-19 Vaccination Program.
    • If a location (Section B) is enrolled in the VFC program in Idaho, then please note the following:
      • At this time, if you list a Primary COVID-19 Vaccine Coordinator who differs from your VFC Primary Vaccine Coordinator, then the COVID-19 Primary will become the VFC Primary. This is due to requirements of the CDC’s current vaccine ordering system.
      • If you list COVID-19 vaccine shipping hours that differ from your location’s current VFC hours, then the most restrictive hours will be selected for all vaccine shipments through the IIP.
  • The brand, model number, and type (i.e., refrigerator, freezer, or ultra-cold) of unit for all vaccine storage and temperature monitoring devices that will be used during the COVID-19 vaccination campaign.
    • A unit’s serial number does not meet this requirement.
    • There will be different COVID-19 vaccines with varied storage requirements. Vaccine storage and handling requirements for each vaccine product will vary from refrigerated (2°C to 8°C) to frozen (-50°C to -15°C) to ultra-cold (-60°C to -80°C) temperatures, and ongoing stability testing may impact these requirements.
    • The calibration date of the temperature monitoring device.
  • Medical license information for providers, at each location, who have prescribing authority or will have oversight of the handling and administration of COVID-19 vaccine (i.e., MD, DO, NP, PA, RPh).

Click the following link to submit your enrollment as a COVID-19 vaccinator in Idaho:

Please refer to the Enrolling an Organization in COVIDReadi resource for step-by-step instructions.

Resources for Idaho COVID-19 Vaccinators


Required Trainings | Providers and key facility staff (overseeing or handling COVID-19 vaccines) must review all required training to participate in Idaho's COVID-19 Vaccination Program. Providers will be notified when new material is released.

     * Providers will be notified when CDC updates these modules with COVID-19 vaccine information.

External Training Links

CDC Vaccine Administration Resource Library

CIIW Webinars: mRNA Vaccines: General Information and Clinical Guidance Update

COCA: What Every Clinician Should Know about COVID-19 Vaccine Safety

COVID-19 Vaccination Training Programs and Reference Materials for Healthcare Professionals

PrepMod Administrator Trainings - January

Idaho Immunization Program Trainings

Educational webinars have started and will be held throughout the COVID-19 vaccination campaign. Topics will include vaccine storage and handling, recommendations, safety, reporting requirements and more.  

Training schedules will be sent to primary and backup COVID-19 Vaccine Coordinators on a weekly basis. Please reach out to these contacts for training links and recordings.

Vaccine Administration

Considerations for Planning Curbside/Drive-Through Vaccination Clinics

Core Infection Prevention and Control Practices for Safe Healthcare Delivery in All Settings

Guidance for Planning Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations

Interim Considerations: Preparing for the Potential Management of Anaphylaxis at COVID-19 Vaccination Sites

Interim Guidance for Routine and Influenza Immunization Services During the COVID-19 Pandemic

Pre-Vaccination Checklist for COVID-19 Vaccines

Product Information Guide for COVID-19 Vaccines and Associated Products

Skills Checklist for Vaccine Administration

Vaccine Administration: Intramuscular (IM) Injection Adults 19 years of age and older

Vaccine Administration: Intramuscular (IM) Injection Children 7 through 18 years of age

Vaccine Administration: Needle Gauge and Length

Moderna COVID-19 Vaccine

Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) | Emergency Use Authorization (EUA) of the Moderna Covid-19 Vaccine to Prevent Coronavirus Disease 2019 (Covid-19) - Translations Available

Fact Sheet for Recipients and Caregivers | Emergency Use Authorization (EUA) of the Moderna Covid-19 Vaccine to Prevent Coronavirus Disease 2019 (Covid-19) in Individuals 18 Years of Age and Older - Translations Available

Standing Orders Moderna COVID-19 Vaccine for 18 Years and Older

Vaccine Preparation and Administration Summary

Pfizer BioNTech COVID-19 Vaccine

Fact Sheet For Healthcare Providers Administering Vaccine (Vaccination Providers) | Emergency Use Authorization (EUA) of the Pfizer-Biontech Covid-19 Vaccine to Prevent Coronavirus Disease 2019 (Covid-19)

Fact Sheet for Recipients and Caregivers | Emergency Use Authorization (EUA) of the Pfizer-Biontech Covid-19 Vaccine to Prevent Coronavirus Disease 2019 (Covid-19) in Individuals 16 Years of Age and Older - Translations Available

Standing Orders Pfizer-BioNTech COVID-19 Vaccine for 16 Years and Older

Vaccine Preparation and Administration Summary